Ä¥°î°æºÏ´ëÇб³º´¿ø The 1st International Symposium on Precision Oncology in Breast Cancer : 2024-05-25
±³À°ÀÏÀÚ : 2024-05-25
±³À°Àå¼Ò : Ä¥°î°æºÏ´ëÇб³º´¿ø 1µ¿ B1 ´ë°´ç
±³À°ÁÖÁ¦ : The 1st International Symposium on Precision Oncology in Breast Cancer
ÁÖÃÖ±â°ü : Ä¥°î°æºÏ´ëÇб³º´¿ø
´ã´çÀÚ : °º´ÁÖ
¿¬¶ôó : 053-200-7281
À̸ÞÀÏ : knuh_bts@naver.com
±³À°Á¾·ù : ³»°ú, ¿Ü°ú
Âü¼®¿¹»óÀÎ : 50¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª : ´ë±¸±¤¿ª½Ã
±³À°½Ã°£ : 5 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 10,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 05¿ù 25ÀÏ ´ë°´ç(1µ¿ÁöÇÏ1Ãþ) 09:30~09:40 Opening remark ( )
±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°´ç(1µ¿ÁöÇÏ1Ãþ) 09:30~10:00 Aquaporin water channels as regulators of cell-cell adhesion proteins Tae-Hwan Kwon(Dean. School of Medicine Kyungpook National University)
±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°´ç(1µ¿ÁöÇÏ1Ãþ) 10:10~10:40 Multimodal chemo-, gene, and immunotherapy for cancer Young Jik Kwon(University of California, Irvine)
±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°´ç(1µ¿ÁöÇÏ1Ãþ) 10:40~11:10 Next-generation diagnostic technology for breast cancer detection and treatment monitoring Hyungsoon Im(Harvard Medical School)
±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°´ç(1µ¿ÁöÇÏ1Ãþ) 11:10~11:40 Towards the precision oncology through innovative clinical trials and translational efforts Young Kwang Chae(Northwestern University)
Åä·Ð 05¿ù 25ÀÏ ´ë°´ç(1µ¿ÁöÇÏ1Ãþ) 11:40~11:50 Q & A ()
½Ä»ç 05¿ù 25ÀÏ 11:50~13:00 Lunch ()
±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°´ç(1µ¿ÁöÇÏ1Ãþ) 13:00~13:20 Prediction of neoadjuvant chemotherapy response using ctDNA in HER2+ breast cancer Soo Jung Lee(Kyungpook National University)
±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°´ç(1µ¿ÁöÇÏ1Ãþ) 13:20~13:40 Deep Learning-based Radiogenomic Prediction Study for Combined Breast MRI and OncotypeDX Recurrence Scores in Breast Cancer: A Fully-Automated Framework Jeeyeon Lee(Kyungpook National University)
±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°´ç(1µ¿ÁöÇÏ1Ãþ) 13:40~14:00 Testing for ESR1 mutations in the ctDNA from ER+/HER2- advanced or metastatic breast cancer Sung-hye Hong(Gencurix Inc.)
Åä·Ð 05¿ù 25ÀÏ ´ë°´ç(1µ¿ÁöÇÏ1Ãþ) 14:00~14:10 Q & A ()
ÈÞ½Ä 05¿ù 25ÀÏ 14:10~14:20 Coffee Break ()
±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°´ç(1µ¿ÁöÇÏ1Ãþ) 14:20~14:35 Prediction of pCR in hormone positive breast cancer In Hee Lee(Kyungpook National University)
±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°´ç(1µ¿ÁöÇÏ1Ãþ) 14:35~14:50 Molecular tuned extracellular blebs for improved vaccination and intracellular delivery Olivia Ritchie(University of California, Irvine)
±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°´ç(1µ¿ÁöÇÏ1Ãþ) 14:50~15:05 Multimodal gene delivery platform for versatile combination cancer therapies Rebecca Lee(University of California, Irvine)
Åä·Ð 05¿ù 25ÀÏ ´ë°´ç(1µ¿ÁöÇÏ1Ãþ) 15:05~15:15 Q & A ()
ÈÞ½Ä 05¿ù 25ÀÏ 15:15~15:25 Coffee Break ()
±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°´ç(1µ¿ÁöÇÏ1Ãþ) 15:25~15:40 LncRNA in breast cancer: SOX2OT and IGF2-AS in tamoxifen-resistant cell lines Byeongju Kang(Kyungpook National University)
±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°´ç(1µ¿ÁöÇÏ1Ãþ) 15:40~15:55 Transplant-Oncology, a new era of innovation for the select cancer patients; DREAM registration study Chan Mi Jung(Northwestern University)
±³À°½Ã°£ 05¿ù 25ÀÏ ´ë°´ç(1µ¿ÁöÇÏ1Ãþ) 15:55~16:10 Development of Chimeric Antigen Receptor (CAR) Based NK Cell Immunotherapy Against Solid Tumor Jee Young Chung(CHA Advanced Research Institute)
Åä·Ð 05¿ù 25ÀÏ ´ë°´ç(1µ¿ÁöÇÏ1Ãþ) 16:10~16:20 Q & A ()
±âŸ 05¿ù 25ÀÏ ´ë°´ç(1µ¿ÁöÇÏ1Ãþ) 16:20~16:30 Closing remark ()